Clinical Scorecard: Lumenis Launches Ocular Surface Care Guide

At a Glance

Key Highlights

• Lumenis announced the field guide at the 2026 American Academy of Ophthalmology annual meeting in New Orleans.
• The guide is organized into clinical care (“The Read”) and practice implementation (“The Rollout”).
• Clinical topics include preoperative screening, treatment selection, patient conversations, postoperative care, and assessing readiness for surgery.
• Implementation topics include demonstrating the value of ocular surface care, assembling a team, and gaining staff buy-in.
• The guide draws on insights from five surgeons and findings from six studies, and includes six tear-out clinical tools.

Guideline-Based Recommendations

Diagnosis

• The guide covers preoperative screening for ocular surface disease that may contribute to the “unhappy 20/20 patient.”

Management

• The guide addresses treatment planning, matching treatment to disease and severity, and determining when a patient is ready for surgery.
• The article describes OptiLIGHT as an FDA-approved intense pulsed light device for dry eye management due to meibomian gland dysfunction.

Monitoring & Follow-up

• The guide covers postoperative care as part of the surgical journey.

Risks

• The article says ocular surface disease may contribute to the “unhappy 20/20 patient.”

Patient & Prescribing Data

Patients undergoing cataract or refractive surgery who may have ocular surface disease.

The guide discusses matching treatment to disease and severity. The article identifies OptiLIGHT as an FDA-approved IPL device for dry eye management due to meibomian gland dysfunction.

Clinical Best Practices

• Incorporate ocular surface screening into preoperative care, as covered by the guide.
• Match treatment to the identified disease and its severity.
• Address patient conversations, postoperative care, and readiness for surgery.
• Plan practice implementation by considering team roles and staff buy-in.

Related Resources & Content